[HTML][HTML] Perspective on oncogenic processes at the end of the beginning of cancer genomics

L Ding, MH Bailey, E Porta-Pardo, V Thorsson… - Cell, 2018 - cell.com
Summary The Cancer Genome Atlas (TCGA) has catalyzed systematic characterization of
diverse genomic alterations underlying human cancers. At this historic junction marking the …

A comprehensive long-read isoform analysis platform and sequencing resource for breast cancer

DFT Veiga, A Nesta, Y Zhao, AD Mays, R Huynh… - Science …, 2022 - science.org
Tumors display widespread transcriptome alterations, but the full repertoire of isoform-level
alternative splicing in cancer is unknown. We developed a long-read (LR) RNA sequencing …

Metastasis inhibition in breast cancer by targeting cancer cell extravasation

MR Cominetti, WF Altei… - Breast Cancer: Targets …, 2019 - Taylor & Francis
The spread of cells from primary tumors toward distant tissues and organs, also known as
metastasis, is responsible for most cancer-associated deaths. The metastasis cascade …

[HTML][HTML] Research progress on RNA− binding proteins in breast cancer

Y Chen, H Qin, L Zheng - Frontiers in Oncology, 2022 - frontiersin.org
Breast cancer is the most common malignancy in women and has a high incidence rate and
mortality. Abnormal regulation of gene expression plays an important role in breast cancer …

hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells

I Passacantilli, P Frisone, E De Paola… - Nucleic Acids …, 2017 - academic.oup.com
Ewing sarcomas (ES) are biologically aggressive tumors of bone and soft tissues for which
no cure is currently available. Most ES patients do not respond to chemotherapeutic …

[HTML][HTML] The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells

C Naro, M De Musso, F Delle Monache… - Journal of Experimental …, 2021 - Springer
Background Triple-negative breast cancer (TNBC) is the most heterogeneous and malignant
subtype of breast cancer (BC). TNBC is defined by the absence of expression of estrogen …

MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression

L Deng, L Liao, YL Zhang, SY Hu, SY Yang, XY Ma… - Cancer Letters, 2023 - Elsevier
Triple-negative breast cancer (TNBC), although highly lethal, lacks validated therapeutic
targets. Here, we report that U2 snRNP-associated SURP motif-containing protein …

[HTML][HTML] The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data

C Mo, L Gao, X Zhu, K Wei, J Zeng, G Chen… - Cancer cell …, 2017 - Springer
Background Ubiquitin-conjugating enzyme E2C (UBE2C) has been previously reported to
correlate with the malignant progression of various human cancers, however, the exact …

[HTML][HTML] Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast …

T Pani, K Rajput, A Kar, H Sharma, R Basak… - Cell Death & …, 2021 - nature.com
Global dysregulation of RNA splicing and imbalanced sphingolipid metabolism has
emerged as promoters of cancer cell transformation. Here, we present specific signature of …

[HTML][HTML] A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing

F Angiolini, E Belloni, M Giordano, M Campioni… - Elife, 2019 - elifesciences.org
The biological players involved in angiogenesis are only partially defined. Here, we report
that endothelial cells (ECs) express a novel isoform of the cell-surface adhesion molecule …